What are the drug interactions and risks of combining flunarizine with domperidone?

Flunarizine and Domperidone Drug Interactions

Combining flunarizine with domperidone carries significant cardiac risk due to additive QT interval prolongation, and this combination should be avoided unless absolutely necessary with intensive cardiac monitoring. Both medications independently prolong the QTc interval and can precipitate life-threatening arrhythmias including torsade de pointes 1, 2.

Primary Concern: Cardiac Arrhythmia Risk

QT Prolongation

• Domperidone is a definite cause of QT prolongation and requires baseline ECG monitoring with measurement of QTc interval, plus serum potassium and magnesium levels before initiation 1
• Flunarizine can cause cardiac dysrhythmias and altered electrocardiographic tracings, though this is less prominently documented than with domperidone 3
• When drugs that prolong QT interval are combined, the risk of torsade de pointes, ventricular tachycardia, and sudden cardiac death increases substantially 2

Real-World Evidence

A community-based practice review found that 69.7% of domperidone patients were coprescribed QT-interacting medications, and among those with follow-up ECGs showing QTc prolongation, 100% were receiving QT-interacting drugs 4. The FDA Adverse Event Reporting System documented that 73.3% of cardiac events with domperidone occurred in patients taking QT-interacting medications 4.

Secondary Concerns

Neurological Effects

• Flunarizine is a dopamine D2 receptor antagonist (Ki = 112 nM) that can cause extrapyramidal symptoms, depression, and tardive dyskinesia 5, 3
• Domperidone is also a peripheral D2 dopamine receptor antagonist
• The combination theoretically increases risk of movement disorders, though domperidone's peripheral action may partially mitigate this

Common Side Effects with Flunarizine

• Weight gain (dose-dependent, more common at 10 mg vs 5 mg) 6
• Sedation and tiredness 7, 8
• Depression (particularly in elderly patients) 7, 9
• Parkinsonism 10

Clinical Management Algorithm

If combination is unavoidable:

1. Baseline assessment:

   • ECG with QTc measurement (withhold if QTc ≥500 ms) 2
   • Serum potassium and magnesium levels 1
   • Screen for risk factors: hypokalemia, hypomagnesemia, fever, inflammatory states, female sex, advanced age 2, 4

2. Monitoring during treatment:

   • Repeat ECG and electrolytes at 4-8 weeks and regularly thereafter 1
   • Withdraw drugs if QTc exceeds 500 ms 2
   • Monitor for neurological adverse effects (movement disorders, depression) 3

3. Dose considerations:

   • Use lowest effective doses: flunarizine 5 mg daily (rather than 10 mg) to reduce side effects 6, 11
   • Domperidone typical dosing 5-10 mg before meals 1

Alternative Strategies

For migraine prophylaxis (flunarizine's primary indication):

• First-line alternatives: propranolol (80-240 mg/day), topiramate (50-100 mg/day), or amitriptyline (30-150 mg/day) 7, 10
• Candesartan (16-32 mg/day) is weight-neutral and lacks depressive effects 10, 9

For gastroparesis (domperidone's primary indication):

• Metoclopramide is suggested as first-line over domperidone 1
• Consider prucalopride or low-dose erythromycin (40-150 mg) as alternatives 1

Critical Contraindications

Absolute contraindications to this combination:

• Baseline QTc ≥500 ms
• Known congenital long-QT syndrome
• Concurrent use of other QT-prolonging drugs (SSRIs, macrolides, antiarrhythmics)
• Uncorrected hypokalemia or hypomagnesemia
• Recent cardiac arrest or ventricular arrhythmias

Relative contraindications:

• Parkinson's disease or movement disorders (flunarizine contraindicated) 10
• Depression (both drugs can worsen) 10, 9
• Elderly patients (higher risk for adverse events) 7, 4

Key Pitfall to Avoid

The most common error is coprescribing these medications without baseline or follow-up ECG monitoring 4. In one study, only 38.1% of domperidone patients received baseline ECGs, and only 25.8% had follow-up monitoring 4. This practice places patients at unacceptable risk for sudden cardiac death.